Skip to content
ppharmaranks
Menu

Best treatments for subarachnoid hemorrhage

3 products may treat subarachnoid hemorrhage, spanning FDA drug classes such as dihydropyridine calcium channel blocker, antifibrinolytic agent. The current highest-rated option is nymalize. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 3 drugs we list for subarachnoid hemorrhage, all are available as lower-cost generics, spanning classes such as dihydropyridine calcium channel blocker, antifibrinolytic agent. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for subarachnoid hemorrhage — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 19, 2026·How we rate

Top-rated picks for subarachnoid hemorrhage: 1. Nymalize · 2. Tranexamic Acid · 3. Nimodipine

Top-rated treatments for subarachnoid hemorrhage, ranked by pharmaranks score
#DrugRatingPharmacy pays
170/100$37View →
270/100$0View →
3Not yet rated$37View →

Full ranking · 3 treatments

Frequently asked

What treats subarachnoid hemorrhage?
Our catalog lists 3 products that may treat subarachnoid hemorrhage, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is nymalize.
What is the best-rated treatment for subarachnoid hemorrhage?
By our independent recall-safety rating — not an efficacy measure — nymalize ranks highest among the products we list for subarachnoid hemorrhage. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat subarachnoid hemorrhage?
Treatments for subarachnoid hemorrhage span FDA drug classes including dihydropyridine calcium channel blocker, antifibrinolytic agent. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.